PUBLISHER: The Business Research Company | PRODUCT CODE: 1826837
PUBLISHER: The Business Research Company | PRODUCT CODE: 1826837
Urinary stents, also referred to as ureteral stents, are medical devices placed in the ureters (the tubes connecting the kidneys to the bladder) to maintain or restore the flow of urine. These stents are commonly used to address blockages, injuries, or narrowing in the ureters caused by conditions such as kidney stones, tumors, or post-surgical complications. They are essential in preventing urine backup, reducing the risk of kidney damage, and alleviating symptoms such as pain or infection.
The main types of urinary or ureteral stents include open-end stents, closed-end stents, double pigtail stents, and multiloop stents. Open-end stents are tubular devices designed to maintain open passages, ensuring unobstructed urine flow in cases of ureteral blockage. Materials used for manufacturing these stents include metallic stents, polymer stents, and biodegradable hydrogel stents. They are applied in treating kidney stones, kidney failure, urinary tract infections, urinary incontinence, and other conditions. The primary end users of these stents are hospitals and specialty centers, ambulatory surgical centers, and academic and research institutes.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The urinary stents or ureteral stents market research report is one of a series of new reports from The Business Research Company that provides urinary stents or ureteral stents market statistics, including the urinary stents or ureteral stents industry global market size, regional shares, competitors with the urinary stents or ureteral stents market share, detailed urinary stents or ureteral stents market segments, market trends, and opportunities, and any further data you may need to thrive in the urinary stents or ureteral stents industry. This urinary stents or ureteral stents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The urinary stents or ureteral stents market size has grown strongly in recent years. It will grow from $0.48 billion in 2024 to $0.51 billion in 2025 at a compound annual growth rate (CAGR) of 5.4%. The growth in the historic period can be attributed to a rise in the prevalence of urological conditions, increasing demand for advanced urinary stent solutions, growing adoption of minimally invasive procedures, rising emphasis on patient comfort and reduced recovery times, and increasing focus on technological advancements in stent materials.
The urinary stents or ureteral stents market size is expected to see strong growth in the next few years. It will grow to $0.65 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to increasing demand for personalized urinary stent solutions, rising healthcare awareness among patients, increasing number of kidney stones, increase in the healthcare investment, and growing geriatric population. Major trends in the forecast period include advancements in minimally invasive techniques, advancements in ureteral stent design, the introduction of new products, technological developments, and advancements in biodegradable hydrogel stents.
The forecast of 6.5% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. patients by driving up the cost of biodegradable ureteral stents sourced from Switzerland and France, exacerbating post-surgical recovery expenses and limiting access to minimally invasive urology procedures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The growing prevalence of kidney diseases is anticipated to drive the expansion of the urinary or ureteral stents market. Conditions such as chronic kidney disease (CKD), kidney stones, urinary tract obstructions, and infections are increasingly affecting kidney function and structure worldwide. Factors such as rising rates of diabetes, hypertension, obesity, aging populations, poor lifestyle habits, environmental influences, and delayed diagnosis contribute to this increase. Urinary stents are crucial for managing these conditions by facilitating proper urine flow, preventing blockages, and supporting kidney function, particularly in cases involving chronic kidney disease, kidney stones, and urinary obstructions. For example, according to the Australian Institute of Health and Welfare, mortality rates from chronic kidney disease rose from 4.2% in 2021 to 6.2% in 2022. Consequently, the increasing prevalence of kidney diseases is fueling the growth of the urinary stents market.
Leading companies in the urinary stents market are prioritizing the development of innovative products designed to enhance patient comfort and minimize risks. Novel stents, characterized by unique features and improvements over existing designs, exemplify this focus. In May 2022, University Hospitals, in partnership with the Ureteral Stent Company, achieved FDA 510(k) clearance for the Relief Ureteral Stent. This advanced stent, made from cutting-edge materials and featuring a unique structure, reduces patient discomfort and lowers the risk of complications such as encrustation or migration. Its enhanced durability and flexibility improve long-term performance for patients with urinary tract obstructions. The FDA clearance underscores the stent's safety and effectiveness, representing a significant advancement in urology.
In February 2023, Olympus Corporation acquired Taewoong Medical Co. Ltd. for approximately $370 million. This acquisition aims to strengthen Olympus's gastrointestinal device portfolio and expand its expertise in minimally invasive treatments by integrating Taewoong Medical's advanced stent technologies. Taewoong Medical, based in Korea, specializes in manufacturing gastrointestinal metallic stents and ureteral stents.
Major players in the urinary stents or ureteral stents market are Becton, Dickinson and Company, Stryker Corporation, Boston Scientific Corporation, Coloplast A/S, Teleflex Incorporated, Cook Medical LLC, Merit Medical Systems Inc., Lepu Medical Technology Co. Ltd., Olympus Corporation, Applied Medical Resources Corporation, Ameco Medical Equipment LLC, Well Lead Medical Co. Ltd., Micro-Tech Nanjing Co. Ltd., Medi-Globe GmbH, Pnn Medical A/S, Taewoong Medical Co. Ltd., Rocamed SAM, HydrUStent SA, Urovision GmbH, MED PRO MEDICAL B.V.
North America was the largest region in the urinary stents or ureteral stents market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in urinary stents or ureteral stents report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the urinary stents or ureteral stents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The urinary stents or ureteral stents market consists of sales of double-J stents, non-coated stents, metallic stents, and percutaneous nephrostomy stents. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Urinary Stents Or Ureteral Stents Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on urinary stents or ureteral stents market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for urinary stents or ureteral stents ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The urinary stents or ureteral stents market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.